Walleye Capital’s Medline Inc MDLN Stock Holding History

Walleye Capital’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18M	Hold	405,273	–	–	0.08%	229
2025 Q4	$17M	Buy	+405,273	New	+$17.1M	0.05%	365

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Walleye Capital's MDLN Position: Q1 2026 in Review

Walleye Capital held its Medline Inc (MDLN) position steady in Q1 2026 at 405,273 shares worth $18M. The position accounts for 0.08% of the portfolio, ranked #229.

Walleye Capital first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Walleye Capital held 405,273 shares of Medline Inc worth $18M as of Q1 2026.
Walleye Capital left its Medline Inc share count unchanged in Q1 2026.
Medline Inc made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #229 holding.
Walleye Capital first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.